Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: Cardiovascular implications

European Respiratory Journal

Volumn 8, Issue 2, 1995, Pages 222-229

  Hedner, J ^a   Darpo, B ^a   Ejnell, H ^a   Carlson, J ^a   Caidahl, K ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiac structure; Hypertension; Nasal continuous positive airway pressure; Norepinephrine; Sleep apnoea syndrome; Sympathetic activity

Indexed keywords

CATECHOLAMINE; NORADRENALIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SYMPATHETIC TONE; URINALYSIS;

BLOOD PRESSURE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; METANEPHRINE; MIDDLE AGE; NOREPINEPHRINE; POSITIVE-PRESSURE RESPIRATION; PROSPECTIVE STUDIES; SLEEP APNEA SYNDROMES; SUPPORT, NON-U.S. GOV'T; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VANILMANDELIC ACID; VENTRICULAR FUNCTION, LEFT;

EID: 0028815333     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.95.08020222     Document Type: Article

References (0)